Planting AS - Search Results

1

The potential of statins as part of anti-cancer treatment.

Sleijfer S, van der Gaast A, Planting AS, Stoter G, Verweij J. Sleijfer S, et al. Among authors: planting as. Eur J Cancer. 2005 Mar;41(4):516-22. doi: 10.1016/j.ejca.2004.12.009. Epub 2005 Jan 11. Eur J Cancer. 2005. PMID: 15737555 Review.

2

Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer.

Planting A, de Jong M, Jansen P, Kerrebijn J, Smith M, Verweij J. Planting A, et al. Eur J Cancer. 2005 Jan;41(1):93-7. doi: 10.1016/j.ejca.2004.09.022. Eur J Cancer. 2005. PMID: 15719490 Clinical Trial.

3

Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.

Planting AS, Stoter G, Verweij J. Planting AS, et al. Eur J Cancer. 1993;29A(4):518-9. doi: 10.1016/s0959-8049(05)80142-x. Eur J Cancer. 1993. PMID: 8435202 Clinical Trial.

4

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma.

Planting AS, van der Burg ME, Goey SH, Schellens JH, Vecht C, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Eur J Cancer. 1996 Oct;32A(11):2026-8. doi: 10.1016/0959-8049(96)00187-6. Eur J Cancer. 1996. PMID: 8943692 Clinical Trial.

5

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck.

Planting AS, de Mulder PH, de Graeff A, Verweij J. Planting AS, et al. Eur J Cancer. 1997 Jan;33(1):61-5. doi: 10.1016/s0959-8049(96)00311-5. Eur J Cancer. 1997. PMID: 9071901 Clinical Trial.

6

Phase I study of DABIS maleate given once every 3 weeks.

van der Burg ME, Planting AS, Stoter G, McDaniel C, Vecht CJ, Verweij J. van der Burg ME, et al. Among authors: planting as. Eur J Cancer. 1991;27(12):1635-7. doi: 10.1016/0277-5379(91)90433-e. Eur J Cancer. 1991. PMID: 1782074

7

Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study.

de Jong FA, Kehrer DF, Mathijssen RH, Creemers GJ, de Bruijn P, van Schaik RH, Planting AS, van der Gaast A, Eskens FA, Janssen JT, Ruit JB, Verweij J, Sparreboom A, de Jonge MJ. de Jong FA, et al. Among authors: planting as. Oncologist. 2006 Sep;11(8):944-54. doi: 10.1634/theoncologist.11-8-944. Oncologist. 2006. PMID: 16951398 Free article. Clinical Trial.

8

A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.

Planting A, van der Gaast A, Schöffski P, Bartkowski M, Verheij C, Noe D, Ferrante K, Verweij J. Planting A, et al. Cancer Chemother Pharmacol. 2005 Feb;55(2):136-42. doi: 10.1007/s00280-004-0905-z. Epub 2004 Sep 29. Cancer Chemother Pharmacol. 2005. PMID: 15592721 Clinical Trial.

9

Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.

de Jonge MJ, Verweij J, van der Gaast A, Valota O, Mora O, Planting AS, Mantel MA, Bosch SV, Lechuga MJ, Fiorentini F, Hess D, Sessa C. de Jonge MJ, et al. Among authors: planting as. Eur J Cancer. 2002 Dec;38(18):2407-15. doi: 10.1016/s0959-8049(02)00492-6. Eur J Cancer. 2002. PMID: 12460785 Clinical Trial.

10

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients.

de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J. de Jongh FE, et al. Among authors: planting as. Br J Cancer. 2003 Apr 22;88(8):1199-206. doi: 10.1038/sj.bjc.6600884. Br J Cancer. 2003. PMID: 12698184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page